Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000089

Options or other derivatives

  • Chief Financial Officer returned 1,250,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Davis Blaine · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-13 Returned to the company : show line 1 in the form Employee Stock Option (right to buy) −1,250,000 $0.79 $987,500 0 D
Loading xslF345X05/wk-form4_1700087199.xml…